J. Mark Sloan, MD

Associate Professor, Medicine

J. Sloan
617.638.7520
820 Harrison Ave

Biography

My clinical expertise is in clinical hematology, especially lymphoma, leukemia, myeloma, amyloidosis, myelodysplasia and bone marrow transplantation. I also have expertise in the treatment of Jehovah’s witnesses

Education

  • Yale University School of Medicine, MD
  • Harverford College, BS

Classes Taught

Publications

  • Published on 4/25/2019

    Pemmaraju N, Lane AA, Sweet KL, Stein AS, Vasu S, Blum W, Rizzieri DA, Wang ES, Duvic M, Sloan JM, Spence S, Shemesh S, Brooks CL, Balser J, Bergstein I, Lancet JE, Kantarjian HM, Konopleva M. Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm. N Engl J Med. 2019 04 25; 380(17):1628-1637. PMID: 31018069.

    Read at: PubMed
  • Published on 1/31/2019

    Leiva O, McMahon L, Sloan JM, Lee J, Lerner A. Recognition of hemophagocytic lymphohistiocytosis in sickle cell vaso-occlusive crises is a potentially lifesaving diagnosis. Haematologica. 2019 Apr; 104(4):e167-e169. PMID: 30705096.

    Read at: PubMed
  • Published on 1/21/2019

    Phull P, Sanchorawala V, Brauneis D, Sloan JM, Siddiqi OK, Quillen K, Sarosiek S. High-dose melphalan and autologous peripheral blood stem cell transplantation in patients with AL amyloidosis and cardiac defibrillators. Bone Marrow Transplant. 2019 Jan 21. PMID: 30664726.

    Read at: PubMed
  • Published on 1/11/2019

    Gupta VK, Brauneis D, Shelton AC, Quillen K, Sarosiek S, Sloan JM, Sanchorawala V. Induction Therapy with Bortezomib and Dexamethasone and Conditioning with High-Dose Melphalan and Bortezomib Followed by Autologous Stem Cell Transplantation for Immunoglobulin Light Chain Amyloidosis: Long-Term Follow-Up Analysis. Biol Blood Marrow Transplant. 2019 May; 25(5):e169-e173. PMID: 30639823.

    Read at: PubMed
  • Published on 1/3/2019

    Dennis M, Maoz A, Hughes D, Sanchorawala V, Sloan JM, Sarosiek S. Bortezomib ocular toxicities: Outcomes with ketotifen. Am J Hematol. 2019 Mar; 94(3):E80-E82. PMID: 30575098.

    Read at: PubMed
  • Published on 12/21/2018

    Angel-Korman A, Stern L, Sarosiek S, Sloan JM, Doros G, Sanchorawala V, Havasi A. Long-term outcome of kidney transplantation in AL amyloidosis. Kidney Int. 2019 Feb; 95(2):405-411. PMID: 30580886.

    Read at: PubMed
  • Published on 6/20/2018

    Nguyen VP, Landau H, Quillen K, Brauneis D, Shelton AC, Mendelson L, Rahman H, Sloan JM, Sarosiek S, Sanchorawala V. Modified High-Dose Melphalan and Autologous Stem Cell Transplantation for Immunoglobulin Light Chain Amyloidosis. Biol Blood Marrow Transplant. 2018 09; 24(9):1823-1827. PMID: 29933072.

    Read at: PubMed
  • Published on 6/14/2018

    Sarosiek S, Quillen K, Sloan JM, Brauneis D, Sanchorawala V. Heparin-induced thrombocytopenia and thrombosis during high dose melphalan and autologous stem cell transplantation. Blood. 2018 Aug 16; 132(7):755-757. PMID: 29903887.

    Read at: PubMed
  • Published on 6/8/2018

    White PS, Phull P, Brauneis D, Sloan JM, Quillen K, Sarosiek S, Sanchorawala V. High-dose melphalan and stem cell transplantation in AL amyloidosis with elevated cardiac biomarkers. Bone Marrow Transplant. 2018 Dec; 53(12):1593-1595. PMID: 29884854.

    Read at: PubMed
  • Published on 4/26/2018

    Pudusseri A, Smith I, Sarnacki D, Brauneis D, Shelton A, Sanchorawala V, Sloan JM, Sarosiek S, Quillen K. Evaluation of a new continuous mononuclear cell collection procedure in a single transplant center cohort enriched for AL amyloidosis patients. Transfus Apher Sci. 2018 Jun; 57(3):411-415. PMID: 29731423.

    Read at: PubMed

View 43 more publications: View full profile at BUMC

View all profiles